WO1999031131A3 - Polypeptide 1 de type calcitonine de mammifere - Google Patents
Polypeptide 1 de type calcitonine de mammifere Download PDFInfo
- Publication number
- WO1999031131A3 WO1999031131A3 PCT/US1998/026940 US9826940W WO9931131A3 WO 1999031131 A3 WO1999031131 A3 WO 1999031131A3 US 9826940 W US9826940 W US 9826940W WO 9931131 A3 WO9931131 A3 WO 9931131A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- document
- date
- polypeptide
- mammalian
- considered
- Prior art date
Links
- 102000017631 Calcitonin-like Human genes 0.000 title 1
- 108050005865 Calcitonin-like Proteins 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract description 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract description 3
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 1
- 102000040430 polynucleotide Human genes 0.000 abstract 1
- 108091033319 polynucleotide Proteins 0.000 abstract 1
- 239000002157 polynucleotide Substances 0.000 abstract 1
- 102000004379 Adrenomedullin Human genes 0.000 description 1
- 101800004616 Adrenomedullin Proteins 0.000 description 1
- 102000055006 Calcitonin Human genes 0.000 description 1
- 108060001064 Calcitonin Proteins 0.000 description 1
- 102000004414 Calcitonin Gene-Related Peptide Human genes 0.000 description 1
- 108090000932 Calcitonin Gene-Related Peptide Proteins 0.000 description 1
- 102000036770 Islet Amyloid Polypeptide Human genes 0.000 description 1
- 108010041872 Islet Amyloid Polypeptide Proteins 0.000 description 1
- ULCUCJFASIJEOE-NPECTJMMSA-N adrenomedullin Chemical compound C([C@@H](C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)NCC(=O)N[C@@H]1C(N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)NCC(=O)N[C@H](C(=O)N[C@@H](CSSC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCC(N)=O)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(N)=O)[C@@H](C)O)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCSC)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@@H](N)CC=1C=CC(O)=CC=1)C1=CC=CC=C1 ULCUCJFASIJEOE-NPECTJMMSA-N 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- BBBFJLBPOGFECG-VJVYQDLKSA-N calcitonin Chemical compound N([C@H](C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(=O)N1[C@@H](CCC1)C(N)=O)C(C)C)C(=O)[C@@H]1CSSC[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1 BBBFJLBPOGFECG-VJVYQDLKSA-N 0.000 description 1
- 229960004015 calcitonin Drugs 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
Definitions
- IPC International Patent Classification
- WO 99 06548 A (GENSET (FR); DUMAS MILNE 1-9 EDWARDS J.-B-; DUCLERT A.; LACROIX B.) 11 February 1999 see abstract see page 6 , l i ne 23 - page 7 , l i ne 20 see page 9 , l i ne 18 - page 10 , l i ne 29 see page 144 - page 148 ; cl aims Seq.ID:41,295
- MUFF R. ET AL. "Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions"
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Toxicology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Priority Applications (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ505265A NZ505265A (en) | 1997-12-18 | 1998-12-18 | Mammalian calcitonin-like polypeptide-1 (Zcalc-1) |
| EP98964775A EP1037914A2 (fr) | 1997-12-18 | 1998-12-18 | Polypeptide 1 de type calcitonine de mammifere |
| AU20024/99A AU2002499A (en) | 1997-12-18 | 1998-12-18 | Mammalian calcitonin-like polypeptide-1 |
| JP2000539054A JP2002508170A (ja) | 1997-12-18 | 1998-12-18 | 哺乳動物カルシトニン様ポリペプチド−1 |
| CA002315247A CA2315247A1 (fr) | 1997-12-18 | 1998-12-18 | Polypeptide 1 de type calcitonine de mammifere |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99393597A | 1997-12-18 | 1997-12-18 | |
| US08/993,935 | 1997-12-18 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO1999031131A2 WO1999031131A2 (fr) | 1999-06-24 |
| WO1999031131A3 true WO1999031131A3 (fr) | 1999-07-29 |
Family
ID=25540096
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US1998/026940 WO1999031131A2 (fr) | 1997-12-18 | 1998-12-18 | Polypeptide 1 de type calcitonine de mammifere |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1037914A2 (fr) |
| JP (1) | JP2002508170A (fr) |
| AU (1) | AU2002499A (fr) |
| CA (1) | CA2315247A1 (fr) |
| NZ (1) | NZ505265A (fr) |
| WO (1) | WO1999031131A2 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6204013B1 (en) * | 1998-06-23 | 2001-03-20 | Millennium Pharmaceuticals, Inc. | MSP-5 nucleic acid molecules and uses therefor |
| WO2000071581A1 (fr) * | 1999-05-20 | 2000-11-30 | Takeda Chemical Industries, Ltd. | Nouveau polypeptide |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999006548A2 (fr) * | 1997-08-01 | 1999-02-11 | Genset | Est 5' pour proteines secretees sans specificite tissulaire |
-
1998
- 1998-12-18 EP EP98964775A patent/EP1037914A2/fr not_active Withdrawn
- 1998-12-18 NZ NZ505265A patent/NZ505265A/en unknown
- 1998-12-18 CA CA002315247A patent/CA2315247A1/fr not_active Abandoned
- 1998-12-18 JP JP2000539054A patent/JP2002508170A/ja active Pending
- 1998-12-18 WO PCT/US1998/026940 patent/WO1999031131A2/fr not_active Application Discontinuation
- 1998-12-18 AU AU20024/99A patent/AU2002499A/en not_active Abandoned
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999006548A2 (fr) * | 1997-08-01 | 1999-02-11 | Genset | Est 5' pour proteines secretees sans specificite tissulaire |
Non-Patent Citations (3)
| Title |
|---|
| DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002104930, Database accession no. AA077497 * |
| DATABASE EMBL NUCLEOTIDE SEQU 1 January 1900 (1900-01-01), XP002104931, Database accession no. AA077040 * |
| MUFF R. ET AL.: "Calcitonin, calcitonin gene-related peptide, adrenomedullin and amylin: homologous peptides, separate receptors and overlapping biological actions", EUROPEAN JOURNAL OF ENDOCRINOLOGY, vol. 133, no. 1, 1 July 1995 (1995-07-01), pages 17 - 20, XP002059455 * |
Also Published As
| Publication number | Publication date |
|---|---|
| EP1037914A2 (fr) | 2000-09-27 |
| JP2002508170A (ja) | 2002-03-19 |
| WO1999031131A2 (fr) | 1999-06-24 |
| CA2315247A1 (fr) | 1999-06-24 |
| NZ505265A (en) | 2002-05-31 |
| AU2002499A (en) | 1999-07-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Quaratino et al. | Similar antigenic surfaces, rather than sequence homology, dictate T-cell epitope molecular mimicry. | |
| Nave et al. | A myofibrillar protein of insect muscle related to vertebrate titin connects Z band and A band: purification and molecular characterization of invertebrate mini-titin | |
| Carrington et al. | Implications of conserved structural motifs in disparate trypanosome surface proteins | |
| Lydekker | Catalogue of the fossil birds in the British Museum (Natural History) | |
| Tournefier et al. | Structure of MHC class I and class II cDNAs and possible immunodeficiency linked to class II expression in the Mexican axolotl | |
| ATE177756T1 (de) | Neue peptide aus einem autoantigen zur verwendung bei immuntherapie von autoimmunkrankheit | |
| EP2258725A3 (fr) | Récepteur de la cytokine zcytor17 | |
| CA2280290A1 (fr) | Recepteurs de netrine | |
| WO1999063086A8 (fr) | Variantes de la proteine-3 de liaison du facteur de croissance de type insulinoide | |
| Roberts et al. | REBASE—restriction enzymes and methylases | |
| WO1999031131A3 (fr) | Polypeptide 1 de type calcitonine de mammifere | |
| FR2677653B1 (fr) | ||
| WO1990007321A3 (fr) | Sequences de guidage de recepteurs de lymphocytes et leurs emplois | |
| GR3030152T3 (en) | A human t-cell receptor of the g-protein coupled receptor family | |
| Katagiri et al. | Isolation of major histocompatibility complex class I cDNA from pink salmon (Oncorhynchus gorbuscha) | |
| Pouchelet et al. | Localization of the 70000 dalton heat-induced protein in the nuclear matrix of BHK cells | |
| Gooday et al. | The genus Bathysiphon (Protista, Foraminiferida) in the northeast Atlantic: SEM observations on the wall structure of seven species | |
| DK0773999T3 (da) | OR-1, en orphan-receptor tilhørende kernereceptorfamilien | |
| Geiger | The association of rhodamine-labelled α-actinin with actin bundles in demembranated cells | |
| WO1998024808B1 (fr) | Inhibition d'allergies provoquees par l'immunoglobuline e grace a un oligopeptide derive de l'immunoglobuline e humaine | |
| Sivakamasundari et al. | Expression and cellular localization of the protein encoded by the 1C7 gene: a recently described component of the MHC | |
| EP1342729A3 (fr) | Anticorps et molécules antisense pour récepteur couplé à la protéine G avec affinité sélective pour l'ATP | |
| ES2308850T3 (es) | Anticuerpos para antigenos de celulas de langerhans de mamiferos y sus usos. | |
| Edmardash et al. | First contribution to the doryctine fauna (Hymenoptera, Braconidae, Doryctinae) of Farasan Archipelago, Saudi Arabia, with new records and the description of a new species | |
| GACHET et al. | Intracellular colocalisation of the translationally controlled protein P23 with cytosketal structures |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM HR HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
| ENP | Entry into the national phase |
Ref document number: 2315247 Country of ref document: CA Kind code of ref document: A |
|
| NENP | Non-entry into the national phase |
Ref country code: KR |
|
| ENP | Entry into the national phase |
Ref document number: 2000 539054 Country of ref document: JP Kind code of ref document: A |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 505265 Country of ref document: NZ |
|
| WWE | Wipo information: entry into national phase |
Ref document number: 1998964775 Country of ref document: EP Ref document number: 20024/99 Country of ref document: AU |
|
| WWP | Wipo information: published in national office |
Ref document number: 1998964775 Country of ref document: EP |
|
| REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
| WWW | Wipo information: withdrawn in national office |
Ref document number: 1998964775 Country of ref document: EP |